S. 2371 (119th)Bill Overview

Safe Baby Formula Act of 2025

Health|Health
Cosponsors
Support
Republican
Introduced
Jul 22, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The Safe Baby Formula Act of 2025 requires the Secretary of Health and Human Services to complete a study within one year on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health. Separately, within 90 days of enactment the Secretary must either establish enforceable action levels for those four metals in infant formula or, by rulemaking, set maximum contamination levels.

Why people may split

Timeline and process: liberals may accept rapid action as precautionary; centrists and conservatives worry 90 days is too short and favors a phased or evidence-based timeline.

Watch point

Relative to its intended legislative type, this bill establishes a clear, limited substantive mandate (study and establishment of contaminant limits for infant formula) and assigns responsibility and deadlines, but its drafting leaves substantial gaps in regulatory mechanics, sequencing, technical specification, funding, and enforcement detail.

The Safe Baby Formula Act of 2025 requires the Secretary of Health and Human Services to complete a study within one year on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health.

Separately, within 90 days of enactment the Secretary must either establish enforceable action levels for those four metals in infant formula or, by rulemaking, set maximum contamination levels.

The bill defines "infant formula" by reference to the Federal Food, Drug, and Cosmetic Act.

Passage60/100

On content alone, the bill addresses a narrow public‑health problem with broadly understandable goals, making it more likely than a sweeping or partisan measure to gain bipartisan support. The main obstacles are administrative feasibility (very short 90‑day requirement for rulemaking), potential lobbying by manufacturers over new contamination limits, and the lack of explicit implementation/transition details. If adjusted to allow a practical rulemaking timeline or paired with appropriations/technical fixes, chances would be higher.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes a clear, limited substantive mandate (study and establishment of contaminant limits for infant formula) and assigns responsibility and deadlines, but its drafting leaves substantial gaps in regulatory mechanics, sequencing, technical specification, funding, and enforcement detail.

Contention55/100

Timeline and process: liberals may accept rapid action as precautionary; centrists and conservatives worry 90 days is too short and favors a phased or evidence-based timeline.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Workers · Federal agenciesManufacturers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitMay reduce infant exposure to toxic metals and associated short- and long-term health risks if stricter limits are set…
  • WorkersCould create demand for expanded analytical testing, compliance, and quality-control services (laboratory technicians,…
  • Federal agenciesEstablishing federal standards can create uniform nationwide requirements, reducing regulatory uncertainty for manufact…
Likely burdened
  • ManufacturersManufacturers—particularly smaller producers—may incur increased compliance costs for testing, reformulation, supplier…
  • Potential burdenThe 90-day deadline to establish action levels or begin rulemaking is very short and may lead to rushed or legally vuln…
  • Potential burdenStricter limits could disrupt supply chains if common raw ingredients exceed new thresholds, potentially causing produc…
03 · Why people split

Why the argument around this bill splits.

Timeline and process: liberals may accept rapid action as precautionary; centrists and conservatives worry 90 days is too short and favors a phased or evidence-based timeline.
Progressive90%

A mainstream liberal would generally favor the bill because it addresses toxic exposures to infants and directs federal action to set contamination limits.

They would welcome quick standards to reduce infant exposure to heavy metals while supporting the mandated study to document health impacts.

However, they would likely press for strong enforcement, funding for testing and monitoring, protections for low-income families (including WIC recipients), and transparent reporting.

Leans supportive
Centrist70%

A centrist/moderate would likely view the bill favorably in its aim to protect infant health but will emphasize process and feasibility.

They will support a study to establish an evidence base and welcome standards to reduce contamination, but they will be concerned that the 90-day requirement to set action or maximum levels is too compressed to permit a careful scientific and regulatory process.

Centrists will look for clarifications about implementation, funding, stakeholder engagement, and contingencies to avoid supply disruptions or undue costs.

Leans supportive
Conservative30%

A mainstream conservative would likely support the goal of protecting infants from toxic contaminants, but worry the bill imposes expedited federal regulatory action that could overreach and impose costs on manufacturers.

They would be skeptical of the 90-day mandate for setting enforceable limits and prefer either a longer, evidence-based process, voluntary industry standards, or state-level action.

They would also be concerned about potential increases in formula prices, supply disruptions, and burdens on smaller producers without clear funding or flexibility.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood60/100

On content alone, the bill addresses a narrow public‑health problem with broadly understandable goals, making it more likely than a sweeping or partisan measure to gain bipartisan support. The main obstacles are administrative feasibility (very short 90‑day requirement for rulemaking), potential lobbying by manufacturers over new contamination limits, and the lack of explicit implementation/transition details. If adjusted to allow a practical rulemaking timeline or paired with appropriations/technical fixes, chances would be higher.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • Existing FDA/HHS actions or standards for these contaminants in infant formula (the bill may overlap with or duplicate existing agency work), which affects how disruptive or novel the mandate is.
  • Administrative feasibility of completing rulemaking or establishing enforcement levels within 90 days; real-world rulemaking typically takes longer and may require notice-and-comment procedures.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Timeline and process: liberals may accept rapid action as precautionary; centrists and conservatives worry 90 days is too short and favors…

On content alone, the bill addresses a narrow public‑health problem with broadly understandable goals, making it more likely than a sweepin…

Unlocked analysis

Relative to its intended legislative type, this bill establishes a clear, limited substantive mandate (study and establishment of contaminant limits for infant formula) and assigns responsibility and deadlines, but its…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis